---
title: "GADICKE ANSBERT — Ownership Dossier"
canonical: https://whiteintel.dev/entity/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96
json: https://whiteintel.dev/api/public/dossier/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96
identifier: sec:0001134655
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GADICKE ANSBERT

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001134655`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96  

## Ownership & control

### Holdings / subsidiaries

- **ACORDA THERAPEUTICS INC** (tenpercentowner) — https://whiteintel.dev/entity/04fe0355-31c1-5552-a4a5-84495cb755d4
- **AKTIS ONCOLOGY, INC.** (tenpercentowner) — https://whiteintel.dev/entity/6782038c-0829-5ef3-9667-77e22dcc26b2
- **Werewolf Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/25dbb1ae-b2ce-5573-9a76-fcb7b2a3eb35
- **Werewolf Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/25dbb1ae-b2ce-5573-9a76-fcb7b2a3eb35
- **iTeos Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/9c37386c-8a35-5e8c-8bfd-692c5ffb060a
- **Entrada Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/e0c7be18-c4b5-5f24-b5ed-00ed7a9178b6
- **TCR2 THERAPEUTICS INC.** (tenpercentowner) — https://whiteintel.dev/entity/f5d5d0ad-b59c-58de-9c7e-fc8dbefdcc32
- **TCR2 THERAPEUTICS INC.** (director) — https://whiteintel.dev/entity/f5d5d0ad-b59c-58de-9c7e-fc8dbefdcc32
- **Cullinan Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da
- **Cullinan Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da
- **Kalaris Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
- **Kalaris Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d

…and **51** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GADICKE ANSBERT** — https://whiteintel.dev/entity/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GADICKE ANSBERT**. Human view: https://whiteintel.dev/entity/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96 · Structured JSON: https://whiteintel.dev/api/public/dossier/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._